Cargando…
EFFECT OF TOCILIZUMAB ON NEW ONSET ATRIAL FIBRILLATION AND MORTALITY IN COVID-19 PATIENTS: AN UMBRELLA REVIEW
Autores principales: | Patel, Aman, Jipescu, Daniel, Liu, Luna, Sharma, Kamal, Mundluru, Giridhar D., Thambidorai, Senthil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Cardiology Foundation. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972432/ http://dx.doi.org/10.1016/S0735-1097(22)03081-9 |
Ejemplares similares
-
ATRIAL ARRHYTHMIAS ASSOCIATED WITH INCREASED MORBIDITY AND MORTALITY IN PATIENTS HOSPITALIZED WITH COVID-19
por: Bailey, Som Aftabi, et al.
Publicado: (2021) -
SYSTEMATIC REVIEW AND META-ANALYSIS OF REMDESIVIR AND BRADYCARDIA IN PATIENTS WITH COVID-19
por: Jipescu, Daniel, et al.
Publicado: (2022) -
ORAL ANTICOAGULATION IN HOSPITALIZED PATIENTS WITH COVID-19, IS IT BENEFICIAL OR HARMFUL ?
por: Gade, Akhil Reddy, et al.
Publicado: (2022) -
THE INCIDENCE OF NEW-ONSET ATRIAL FIBRILLATION IN HOSPITALIZED COVID-19 PATIENTS RECEIVING HIGH DOSE CORTICOSTEROIDS
por: McMahan, Daniel, et al.
Publicado: (2022) -
VENOUS THROMBOEMBOLISM IN HOSPITALISED COVID PATIENTS: AN UMBRELLA REVIEW
por: Shah, Komal, et al.
Publicado: (2022)